The information contained in these documents is a statement of consensus of BC Cancer Agency professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. Use of these documents is at your own risk and is subject to BC Cancer Agency's terms of use available at www.bccancer.bc.ca/legal.htm.
Please note: All links in the table below open PDF documents
.
| Bladder Protocol Code and Description |
Available Documents
(revision date indicated in red) |
| UGUAJPG: Adjuvant therapy for urothelial carcinoma using cisplatin and gemcitabine. |
- Protocol (01 May 2009)
- Preprinted order (01 May 2009) |
| GUAVPG: Palliative therapy for urothelial carcinoma using cisplatin and gemcitabine. |
- Protocol (01 Sep 2009)
- Preprinted order (01 May 2009)
- Patient Handout (01 Jul 2008) |
| GUBCG: Therapy for high risk superficial transitional cell bladder cancer using BCG. |
- Protocol (01 May 2009) |
| GUBCGIFN: Palliative Therapy for BCG-Refractory Superficial High-Grade Transitional Cell Carcinoma Bladder with BCG and Interferon. |
- Protocol (01 May 2009) |
| GUBCV: Therapy for transitional cell cancers using Carboplatin-Vinblastine. |
- Protocol (01 May 2009)
- Preprinted order (01 May 2009) |
| GUBPWRT (formerly GUBPW): Treatment of Locally Advanced Bladder Cancer with Weekly Cisplatin and Concurrent Radiation. |
- Protocol (01 May 2009)
- Preprinted order (01 Jun 2009)
- Patient Handout (01 May 2008) |
| GUBPRT (formerly GUBRADC): Treatment of Locally Advanced Bladder Cancer Using Concurrent Cisplatin with Radiation |
- Protocol (01 May 2009)
- Preprinted order (01 May 2009)
- Patient Handout (01 May 2008) |
| GUMVAC: Therapy for transitional cell cancers of the urothelium using Methotrexate, Vinblastine, Doxorubicin and Cisplatin. |
- Protocol (01 May 2009)
- Preprinted order (01 May 2009) |
| UGUNAJPG: Neo-Adjuvant Therapy for Urothelial Carcinoma Using Cisplatin and Gemcitabine. |
- Protocol (01 May 2009)
- Preprinted order (01 May 2009) |
Back to top
| Prostate Protocol Code and Description |
Available Documents
(revision date indicated in red) |
| GUEMCYT: Therapy for androgen-independent prostate cancer using estramustine phosphate. |
- Protocol (01 May 2009)
- Preprinted order (01 May 2009) |
| GUPDOC: Palliative Therapy for Metastatic Hormone Refractory Prostate Cancer Using Docetaxel. |
- Protocol (28 Aug 2009)
- Preprinted order (01 May 2009) |
| GUPKETO: Short term hormonal management for metastatic prostate cancer using high dose Ketoconazole therapy. |
- Protocol (01 Dec 2009) |
| GUPLHRH: Therapy for prostate cancer using LHRH agonist (Goserelin, Leuprolide or Buserelin). |
- Protocol (01 May 2009)
- Preprinted order (01 May 2009) |
| GUPMX: Palliative therapy for hormone-refractory prostate cancer using Mitoxantrone and Prednisone. |
- Protocol (01 May 2009)
- Preprinted order (01 May 2009) |
| GUPNSAA: Non-steroidal treatment of prostate cancer |
- Protocol (01 Jul 2009)
- Preprinted order (01 Jul 2009) |
Back to top
| Testicular Protocol Code and Description |
Available Documents
(revision date indicated in red) |
| GUBEP: Curative Therapy for germ cell cancer using Bleomycin, Etoposide and Cisplatin. |
- Protocol (01 Feb 2010)
- Preprinted order (01 Mar 2010)
- Patient Handout (01 Jun 2008) |
| GUEP: Therapy for nonseminoma germ cell cancer using Etoposide-Cisplatin. |
- Protocol (01 Mar 2010)
- Preprinted order (01 Mar 2010) |
| GUSCARB: Adjuvant therapy for stage I high risk seminoma using carboplatin. |
- Protocol (01 May 2009)
- Preprinted order (01 May 2009) |
| UGUTAXGEM: Palliative therapy for germ cell cancers using paclitaxel and gemcitabine. |
- Protocol (01 May 2009)
- Preprinted order (01 May 2009) |
| UGUTIP: Therapy for Relapsed Testicular Germ Cell cancer using paclitaxel, lfosfamide and Cisplatin (TIP) |
- Protocol (01 Nov 2009)
|
| GUVEIP: Consolidation/ Salvage Treatment for Germ Cell Cancer Using Vinblastine, Cisplatin, Ifosfamide and Mesna. |
- Protocol (01 Nov 2009) |
| GUVIP2: Nonseminoma Consolidation/Salvage Protocol using Etoposide, Cisplatin, Ifosfamide, MESNA. |
- Protocol (01 May 2009) |
Back to top
Back to top